本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BioNTech SE

102.76
-1.3900-1.33%
成交量:53.65萬
成交額:5,445.25萬
市值:246.59億
市盈率:-35.83
高:103.71
開:103.17
低:99.89
收:104.15
資料載入中...
2024/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 | BioNTech 大股東 ATHOS KG 擬減持55605股,總價約693萬美元
2024/09/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/16

關聯方擬減持公告

Form 144 | BioNTech SE 10%股東 ATHOS KG 擬減持50萬股,總價約6170萬美元
2024/09/16

關聯方擬減持公告

Form 144 | BioNTech SE 股東 ATHOS KG 擬減持90000股,總價約1134萬美元
2024/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/20

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities